Breaking News Instant updates and real-time market news.

AMRN

Amarin

$17.71

0.43 (2.49%)

13:50
05/24/19
05/24
13:50
05/24/19
13:50

Amarin attracts call buyers in contracts that expire in one week

Amarin attracts call buyers in contracts that expire in one week. The stock up 2.2% to $17.66 and May 31st 19 calls see a flurry of activity in small lots midday from 22 to 25c per contract. 12.3K changed hands against 457 open interest and the calls, which are struck 7.5% above spot and expire next Friday, now trade 30c. Implied volatility in the 5/31 term is 66.5% and the highest of any terms (in 2019) in AMRN options. Earnings last reported 5/1.

AMRN Amarin
$17.71

0.43 (2.49%)

05/17/19
BTIG
05/17/19
INITIATION
Target $5
BTIG
Buy
Matinas BioPharma initiated with a Buy at BTIG
BTIG analyst Robert Hazlett initiated Matinas BioPharma (MTNB) with a Buy rating and $5 price target, noting that the company's lead candidate, MAT9001, showed superior TG lowering versus Amarin's(AMRN) Vascepa. He thinks the Omega 3 class can have multiple winners and estimates MAT9001 peak revenue of greater than $2B.
05/02/19
SBSH
05/02/19
NO CHANGE
Target $23
SBSH
Buy
Amarin selloff creates attractive entry point, says Citi
Citi analyst Joel Beatty believes the selloff yesterday in shares of Amarin (AMRN) brings an attractive entry point. He raised his price target for the stock to $23 from $20 and keeps a Buy rating on the name. The analyst sees five potential upside catalysts this year, including a likely supportive ICER cost-effectiveness review and potential priority review from the FDA. Further, while an acquisition of Amarin is possible, the company acquiring The Medicines Co. (MDCO) or Esperion (ESPR) "could also be a viable path," says Beatty.
04/29/19
JEFF
04/29/19
NO CHANGE
Target $30
JEFF
Buy
Amarin settlement could be 'key catalyst' for shares, says Jefferies
Recent updates in the dosing patent litigation between Amarin (AMRN) and Hikma and Reddy's show the sides have been progressing and both cases were moved under the same judge in Nevada, Jefferies analyst Michael Yee tells investors in a research note. The analyst believes uncertainty around the ongoing litigation presents a risk for investors and that there is a perception on the Street that the cases impactsany potential acquisition transaction for Amarin until there is clarity. With Judge Du setting a trial date for January 13, 2020, at least a timeline for one of the two major cases is known, Yee writes. He believes a potential "key catalyst" could be a settlement beforehand. The analyst continues to think another settlement, like the one Amarin reached with Teva (TEVA), and removal of the overhang is "likely in time and is a win-win for all parties." This "could be quite important" for Amarin shares, says Yee. He keeps a Buy rating on Amarin with a $30 price target.
04/24/19
JEFF
04/24/19
NO CHANGE
Target $30
JEFF
Buy
Jefferies sees potential beat for Amarin on growing Q1 Vascepa sales
Jefferies analyst Michael Yee says that despite Amarin's management cautioning to expect seasonality in Q1, scripts are up over 16% quarter over quarter, appearing to track to $75M-$80M in Q1 versus consensus of $67M and Jefferies at $79M. Historically, Vascepa sales have declined in Q1 over the past couple of years, but the analyst sees an increase this year instead due to major new CVOT data during Q4 now published in the NEJM, huge salesforce increase to 400 from 150 recently, and positive doctor channel checks suggesting reimbursement has not been much issue. Yee believes 2019 guidance of $350M appears conservative. He reiterates a Buy rating and $30 price target on the shares.

TODAY'S FREE FLY STORIES

LAUR

Laureate Education

$15.20

-0.17 (-1.11%)

14:00
06/24/19
06/24
14:00
06/24/19
14:00
Options
Odd bullish block in Laureate Education on CBOE »

Odd bullish block in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCCY

1st Constitution Bancorp

$18.00

-0.695 (-3.72%)

13:59
06/24/19
06/24
13:59
06/24/19
13:59
Upgrade
1st Constitution Bancorp rating change  »

1st Constitution Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$143.15

-10.925 (-7.09%)

13:58
06/24/19
06/24
13:58
06/24/19
13:58
Hot Stocks
PizzaRev announces partnership to offer Beyond Meat sausage topping »

PizzaRev announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:55
06/24/19
06/24
13:55
06/24/19
13:55
General news
Fed funds futures are firmer with Treasuries »

Fed funds futures are…

KPTI

Karyopharm

$6.30

-0.13 (-2.02%)

13:50
06/24/19
06/24
13:50
06/24/19
13:50
Options
Bullish call spread opened in Karyopharm Therapeutics »

Bullish call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

FDS

FactSet

$293.78

-4.31 (-1.45%)

, LEN

Lennar

$51.67

0.35 (0.68%)

13:46
06/24/19
06/24
13:46
06/24/19
13:46
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

FDS

FactSet

$293.78

-4.31 (-1.45%)

LEN

Lennar

$51.67

0.35 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 27

    Jun

  • 28

    Jun

SPOT

Spotify

$149.91

1.74 (1.17%)

, AAPL

Apple

$199.07

0.3 (0.15%)

13:46
06/24/19
06/24
13:46
06/24/19
13:46
On The Fly
Analyst says sell Spotify on publisher rates risk, competition »

Evercore ISI analyst…

SPOT

Spotify

$149.91

1.74 (1.17%)

AAPL

Apple

$199.07

0.3 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

STNG

Scorpio Tankers

$26.23

0.18 (0.69%)

13:45
06/24/19
06/24
13:45
06/24/19
13:45
Conference/Events
Scorpio Tankers management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

AG

First Majestic

$7.77

0.31 (4.16%)

13:45
06/24/19
06/24
13:45
06/24/19
13:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$21.23

-0.51 (-2.35%)

13:43
06/24/19
06/24
13:43
06/24/19
13:43
Conference/Events
Coherus Biosciences management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

MDEVF

Melco International

$0.00

(0.00%)

, MLCO

Melco Resorts & Entertainment

$21.41

-0.21 (-0.97%)

13:40
06/24/19
06/24
13:40
06/24/19
13:40
Recommendations
Melco International, Melco Resorts & Entertainment analyst commentary  »

Melco International could…

MDEVF

Melco International

$0.00

(0.00%)

MLCO

Melco Resorts & Entertainment

$21.41

-0.21 (-0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMB

Williams

$27.24

-0.45 (-1.63%)

13:35
06/24/19
06/24
13:35
06/24/19
13:35
Options
Williams put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLSA

Tiziana Therapeutics

$8.50

(0.00%)

13:32
06/24/19
06/24
13:32
06/24/19
13:32
Hot Stocks
Tiziana says newly published article supports oral monoclonal antibody platform »

Tiziana Life Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$262.82

0.42 (0.16%)

13:25
06/24/19
06/24
13:25
06/24/19
13:25
Options
NetEase call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$199.18

0.41 (0.21%)

13:21
06/24/19
06/24
13:21
06/24/19
13:21
Periodicals
Apple rolls out fifth iOS 12.4 beta ahead of Apple Card launch, 9to5Mac says »

Apple is rolling out the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/24/19
06/24
13:17
06/24/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFMD

Affimed N.V.

$2.97

-0.45 (-13.16%)

13:16
06/24/19
06/24
13:16
06/24/19
13:16
Hot Stocks
Affimed falls 13% after announcing clinical update on AFM13 in CD30 lymphomas »

Earlier today, Affimed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/24/19
06/24
13:16
06/24/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSIT

Insight Enterprises

$56.89

0.7 (1.25%)

, PCMI

PCM, Inc.

$34.67

10.315 (42.36%)

13:13
06/24/19
06/24
13:13
06/24/19
13:13
Recommendations
Insight Enterprises, PCM, Inc. analyst commentary at Stifel »

Insight Enterprises price…

NSIT

Insight Enterprises

$56.89

0.7 (1.25%)

PCMI

PCM, Inc.

$34.67

10.315 (42.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

NBL

Noble Energy

$21.32

-0.24 (-1.11%)

, OXY

Occidental Petroleum

$50.09

-0.53 (-1.05%)

13:07
06/24/19
06/24
13:07
06/24/19
13:07
Periodicals
U.S. natural gas prices plummet in June, Forbes says »

According to Jude…

NBL

Noble Energy

$21.32

-0.24 (-1.11%)

OXY

Occidental Petroleum

$50.09

-0.53 (-1.05%)

EOG

EOG Resources

$90.84

-1.57 (-1.70%)

DVN

Devon Energy

$27.93

-0.31 (-1.10%)

APA

Apache

$29.14

-0.52 (-1.75%)

CHK

Chesapeake

$1.89

-0.055 (-2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 02

    Aug

  • 27

    Aug

  • 13

    Nov

D

Dominion

$79.35

1.01 (1.29%)

13:05
06/24/19
06/24
13:05
06/24/19
13:05
Options
Dominion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDS

Aridis Pharmaceuticals

$9.65

-0.55 (-5.39%)

13:04
06/24/19
06/24
13:04
06/24/19
13:04
Hot Stocks
Aridis' treatment of lung infections in CF patients granted orphan designation »

Aridis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELF

e.l.f. Beauty

$13.37

0.3 (2.30%)

, COTY

Coty

$13.09

-0.12 (-0.91%)

13:02
06/24/19
06/24
13:02
06/24/19
13:02
On The Fly
Ulta, Sally Beauty slide after Amazon announces Professional Beauty Store »

Shares of Ulta Beauty…

ELF

e.l.f. Beauty

$13.37

0.3 (2.30%)

COTY

Coty

$13.09

-0.12 (-0.91%)

REV

Revlon

$21.48

-0.65 (-2.94%)

EL

Estee Lauder

$183.51

2.21 (1.22%)

AMZN

Amazon.com

$1,907.03

-3.39 (-0.18%)

SBH

Sally Beauty

$12.83

-1.96 (-13.25%)

ULTA

Ulta Beauty

$342.74

-13.03 (-3.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 01

    Jul

  • 09

    Jul

  • 10

    Jul

  • 19

    Aug

  • 29

    Aug

MCRB

Seres Therapeutics

$2.99

0.31 (11.57%)

, PSEC

Prospect Capital

$6.62

0.02 (0.30%)

13:01
06/24/19
06/24
13:01
06/24/19
13:01
On The Fly
Fly Insider: Seres, Tiffany among week's notable insider transactions »

Welcome to "Fly Insider,"…

MCRB

Seres Therapeutics

$2.99

0.31 (11.57%)

PSEC

Prospect Capital

$6.62

0.02 (0.30%)

SGMS

Scientific Games

$18.30

-0.69 (-3.63%)

FCNCA

First Citizens

$437.76

2.47 (0.57%)

PBF

PBF Energy

$27.64

-0.825 (-2.90%)

GIII

G-III Apparel

$27.96

0.04 (0.14%)

TIF

Tiffany

$92.98

-0.66 (-0.70%)

NVDA

Nvidia

$153.37

1.63 (1.07%)

ZAYO

Zayo Group

$33.00

-0.04 (-0.12%)

WRB

W. R. Berkley

$67.11

0.23 (0.34%)

ZBRA

Zebra Technologies

$201.50

1.35 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 15

    Aug

BCOM

B Communications Ltd.

$1.90

0.05 (2.70%)

12:59
06/24/19
06/24
12:59
06/24/19
12:59
Hot Stocks
B Communications Ltd. says board approves Searchlight transaction »

B Communications Ltd.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.